
The ACCC (Australian Competition & Consumer Commission) has accepted a CEU from Visa in relation to concerns that it may have limited competition in the debit card acceptance market through its dealings with large merchants.
The ACCC was concerned that Visa’s strong market position in the credit card acceptance market could be leveraged to limit competition in the debit card acceptance market by tying cheaper ‘strategic merchant rates’ for credit card transactions to commitments from merchants to process Visa branded dual network debit card transactions via the Visa network rather than through eftpos.
The fees paid by a merchant for dual-network debit card payments can vary depending on the debit card network used for processing the transaction. Almost all Visa debit cards are dual-network debit cards that can be processed using either the Visa or eftpos debit card network, Australia’s domestic debit card network.
Since 2017, merchants have been able to choose whether contactless payments made using a Visa branded dual-network debit card are processed by Visa or eftpos, an RBA (Reserve Bank of Australia) initiative known as ‘least-cost routing’.
The ACCC investigated allegations that Visa may have engaged in anti-competitive conduct, amid concerns that Visa could influence merchants’ choice of debit card network, thereby diminishing competition between Visa and eftpos in relation to debit card acceptance.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas